What is Erasca, Inc.'s investment proceeds?

Erasca, Inc. (ERAS) reported investment proceeds of $100.83M in Q1 2026.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Erasca, Inc. ERAS Investment Proceeds

Investment Proceeds at other companies

IDEAYA Biosciences, Inc.IDYA

$162.53M-12.8%

Relay Therapeutics, Inc.RLAY

$83.8M+29.3%

BillionToOne, Inc. BLLN

$0—

Arrowhead ResearchARWR

$115.34M-2.4%

Jazz PharmaceuticalsJAZZ

$520M+67.7%

Ionis PharmaceuticalsIONS

$752.82M+52.2%

Other financials

Income statement

See full

Operating income-$187.9M-427%

Net income-$183.4M-492%

EPS (diluted)-$0.60-445%

Balance sheet

See full

Cash & equivalents$47.3M-33.0%

Total debt$46.0M-9.6%

Total equity$393.5M-1.5%

Total assets$461.2M-2.1%

Cash flow

See full

Operating cash flow-$27.4M+13.2%

CapEx$36.0K-56.6%

Free cash flow-$27.4M+13.3%

Valuation

See full

Market cap$4.69B+1,196%

Returns & leverage

See full

Return on equity-69.9%+77.1pp

Debt / equity0.1×0.0×

Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Erasca, Inc.'s investment proceeds?: Erasca, Inc. (ERAS) reported investment proceeds of $100.83M in Q1 2026.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.